Viralgen has partnered biotech company Trogenix, aiming to accelerate the development of gene therapy for glioblastoma.

The Vivo Opportunity Fund has already catalysed a plethora of medicine development via biotech investments in its first two ...

BioVaxys Technology and Sona Nanotech have signed an agreement to develop cancer therapeutics, utilising the DPX platform ...

ARS Pharmaceuticals has announced the availability of neffy (epinephrine nasal spray) 1mg in the United States.

This move comes a day after President Trump signed an executive order to streamline approval processes for domestic plants.